Journal article

Intestinal absorption and cell transforming potential of PhIP-M1, a bacterial metabolite of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)


Authors listNicken, P; Willenberg, I; von Keutz, A; von Elsner, L; Hamscher, G; Vanhaecke, L; Schroder, B; Breves, G; Schebb, NH; Steinberg, P

Publication year2015

Pages92-98

JournalToxicology Letters

Volume number234

Issue number2

ISSN0378-4274

DOI Linkhttps://doi.org/10.1016/j.toxlet.2015.02.015

PublisherElsevier


Abstract
Previous studies have shown that in the rat, the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is only absorbed to a limited extent in the small intestines and that a major fraction of unmetabolised PhIP reaches the colon. Moreover, PhIP is extensively metabolised when incubated with human stool samples to a major derivative, 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido [3',2':4,5]imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1). In the present study, the uptake and transport of PhIP-M1 in Ussing chamber experiments, its cytotoxicity in the different segments of the Fischer 344 rat gut and its transforming potential in the BALB/c 3T3 cell transformation assay were analysed. At the most, 10-20% of the PhIP-M1 amount added to the mucosal compartment of the Ussing chambers per segment were absorbed within 90min. Therefore, the amount of PhIP-M1 detected in the tissues as well as in the serosal compartment of the Ussing chambers was extremely low. Moreover, human-relevant concentrations of PhIP-M1 were not cytotoxic and did not induce the malignant transformation of BALB/c 3T3 cells. In conclusion, even if one would assume that 100% of the daily amount of PhIP ingested by a human being is converted into PhIP-M1 in the colon, this concentration most probably would not lead to cytotoxicity and/or carcinogenicity in the colorectal mucosa.



Citation Styles

Harvard Citation styleNicken, P., Willenberg, I., von Keutz, A., von Elsner, L., Hamscher, G., Vanhaecke, L., et al. (2015) Intestinal absorption and cell transforming potential of PhIP-M1, a bacterial metabolite of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Toxicology Letters, 234(2), pp. 92-98. https://doi.org/10.1016/j.toxlet.2015.02.015

APA Citation styleNicken, P., Willenberg, I., von Keutz, A., von Elsner, L., Hamscher, G., Vanhaecke, L., Schroder, B., Breves, G., Schebb, N., & Steinberg, P. (2015). Intestinal absorption and cell transforming potential of PhIP-M1, a bacterial metabolite of the heterocyclic aromatic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Toxicology Letters. 234(2), 92-98. https://doi.org/10.1016/j.toxlet.2015.02.015


Last updated on 2025-21-05 at 15:41